CORRECTION article

Front. Cell. Neurosci., 26 May 2021

Sec. Cellular Neuropathology

Volume 15 - 2021 | https://doi.org/10.3389/fncel.2021.687301

Corrigendum: A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP

  • Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience, Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel

Article metrics

View details

1

Citations

1,7k

Views

552

Downloads

In the original article, there were inconsistencies when comparing one by one the panels of Figure 4A in the main text and the representative extended immunoblot results in Supplementary Figure S3, as published. Thus, some of the representative images in the main text were unfortunately represented by extended mirrored, duplicated and rotated blots as explained below. It should be emphasized that for scientific rigor and data corroboration, each experiment was performed in triplicates and repeated three times and each immunoblot was exposed at least three times (three films), hence, the blot shown as a full image in the original supplementary material is a representative picture, as specifically stated in the original Supplementary Figure S3 legend. To maintain scientific rigor, there were 36 blots and almost 100 films. Our mistakes, corrected below, stem from an unfortunate mix-up coupled with an extremely high similarity between all repetitive experiments, we apologize for the mistakes.

Figure 4

Supplementary Figure S3

Corrections have been made to Figure 4, panel A, and Supplementary Figure S3. The corrected figures are shown below.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

tau, microtubules, EBs, ADNP, SKIP

Citation

Ivashko-Pachima Y and Gozes I (2021) Corrigendum: A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP. Front. Cell. Neurosci. 15:687301. doi: 10.3389/fncel.2021.687301

Received

29 March 2021

Accepted

28 April 2021

Published

26 May 2021

Volume

15 - 2021

Edited and reviewed by

Dirk M. Hermann, University of Duisburg-Essen, Germany

Updates

Copyright

*Correspondence: Illana Gozes ;

This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics